Hello, Guest
Login
Sign Up
 
 

OTC Stock Picks Provides a Report on Hot Penny Stocks - MFTH, GNBT, ACTC, VDSC

 
 
Repost This

stamford, CT -- (SBWIRE) -- 01/31/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. These are the awesome penny stocks that the ‘underground penny stock experts’ brag about in our penny stock blogs.

Medisafe 1 Technologies Corp (OTC:MFTH) percentage change climbed 44.83% to close at $0.0042 with the total traded volume of 44.14 million shares, more than average volume of 9.52 million.

The Company’s year to date performance remained optimistic with the rise of 200%. If we look at the last 6 months of trade, that is in the bullish zone with an increase of 147.06%

The company has a total of 540.93 million outstanding shares and its total market capitalization is $2.27 million. The 52-week high price of the stock remained $0.03.

Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.

What was the Moving Force behind MFTH's Bullish Run? Read This Research Report

Generex Biotechnology Corporation (OTC:GNBT) started its trading session with the price $0.04 and closed at $0.0638 by increasing 59.50%. Day trading range of GNBT was $0.04 -$0.06.

A review of its graph:

Previous 5 days graph demonstrated a positive move of 63.59%. GNBT’s quarterly performance remained in the green with the percentage of 16%, while its year to date performance remained 155.2%. The beta of GNBT stands at 1.60.

GNBT’s stocks traded with total volume of 41.79 million shares, while the average trading volume remained 4.36 million shares.

For How Long Will GNBT Fight for Profitability? Read This Trend Analysis report

Advanced Cell Technology, Inc. (OTC:ACTC), during the previous trading session, the stock showed a positive movement of 1.92%.

Graph values of the stock demonstrate these trends:

Year to date performance of the stock remained positive with the rise of 43.27%. ACTC traded with volume of 14.06 million shares, while its average trading volume remained 13.96 million shares.

Currently, the company has a market capitalization of $174.87 million. The stock’s closing price was $0.0798, while it started its day-trade at $0.08. Its 52-week price range was $0.05- $0.14.

Will ACTC Continue To Move Higher? Find Out Here

ALAS DEFENSE SYS INC (PINK:VDSC) opened at $0.01 and, as day trade closed, its price was $0.0070 after decreasing -12.50% .The market capitalization of VDSC was 936,200 shares. Total traded volume of the stock was 20.20 million shares, while the company’s average volume remained 22.99 million shares.

During the last 5 trades, the stock jumped almost 89.19%. During its last 3 months, it climbed with 536.36%. Its year to date performance remained progressive 677.78%.

Why Should Investors Buy VDSC After the Recent Fall? Just Go Here and Find Out

About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.

Disclaimer
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company websites, but this should not be construed as a recommendation to buy or sell.